Search PubMed⌕ Search

PubMed · 645638

Multivariate estimation of reference ranges.

Abstract

This paper describes a new method for estimating reference ranges of 21 frequently performed laboratory tests utilizing routine test results of selected hospital patients. Computer programs perform the selection of patient records and the statistical analysis. The patient selection criteria of (1) short hospital stay and (2) short laboratory record provide a data base rich in normal results. The statistical program excludes records with excessive variation, and in repeated data-exclusion passes through the data base progressively narrows the range of acceptability. The decision to exclude a record is based on the "pooled variation." The average value of the "pooled variation" increases as the range is narrowed. This approach insures that the process stops after a few passes, and the most consistent data remain included in the calculation of reference ranges. Statistical properties of the data sets, as well as comparison with normal ranges for healthy subjects and review of 560 clinical charts, support the idea that serviceable reference ranges are obtained. The method is suitable for monitoring the reference ranges of the laboratory at frequent intervals.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B M Horvath. 1978. Multivariate estimation of reference ranges.. https://doi.org/10.1093/ajcp%2F69.4.398

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗